Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0012739 (
disseminated intravascular coagulation
)
8,673
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The protein-polysaccharide fraction (
AAF
) isolated from the coelomic fluid of the earthworm Dendrobaena veneta destroys C. albicans cells by changing their morphology, disrupting cell division, and leading to cell death. Morphological changes in C. albicans cells induced by treatment with
AAF
were documented using
DIC
, SEM, and AFM. Congo Red staining showed that the fungal wall structure was changed after incubation with
AAF
. The effect on C. albicans cell walls was shown by AFM analysis of the surface roughness of fungal cell walls and changes in the wall thickness were visualized using Cryo-SEM. The FTIR analysis of C. albicans cells incubated with
AAF
indicated attachment of protein or peptide compounds to the fungal walls. The intact LC-ESI-MS analysis allowed accurate determination of the masses of molecules present in
AAF
. As shown by the chromatographic study, the fraction does not cross biological membranes. The Cryo-TEM analysis of
AAF
demonstrated the ability of smaller subunits to combine into larger agglomerates.
AAF
is thermally stable, which was confirmed by Raman spectroscopy.
AAF
can be considered as a potential antifungal antibiotic with activity against clinical C. albicans strains.
...
PMID:Candida albicans cell wall as a target of action for the protein-carbohydrate fraction from coelomic fluid of Dendrobaena veneta. 3300 52